Australia markets closed

60 Degrees Pharmaceuticals, Inc. (SXTP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2731-0.0087 (-3.09%)
At close: 04:00PM EDT
0.2731 0.00 (0.00%)
After hours: 07:26PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
352.864
253.573
223.208
1,160
2,181
Cost of revenue
466.867
474.55
432.37
850.742
702.989
Gross profit
-114.003
-220.977
-209.162
309.598
1,478
Operating expenses
Research development
904.958
691.77
525.563
5,511
806.683
Selling general and administrative
4,542
4,242
1,304
1,115
1,458
Total operating expenses
5,422
4,934
1,541
1,434
1,847
Operating income or loss
-5,536
-5,155
-1,750
-1,124
-368.914
Interest expense
1,147
2,287
3,989
3,173
2,678
Total other income/expenses net
5,894
3,628
-437.48
37.515
-0.121
Income before tax
-788.031
-3,814
-6,177
-4,259
-3,047
Income tax expense
0.25
0.25
0.5
1
1
Income from continuing operations
-788.281
-3,814
-6,178
-4,260
-3,048
Net income
-735.171
-3,766
-6,182
-4,252
-3,034
Net income available to common shareholders
-735.171
-3,766
-6,182
-4,252
-3,034
Basic EPS
-0.59
-0.99
-1.11
-0.76
-0.54
Diluted EPS
-0.59
-0.99
-1.11
-0.76
-0.54
Basic average shares
5,800
3,960
5,570
5,570
5,570
Diluted average shares
5,800
3,960
5,570
5,570
5,570